JPS57112329A - Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid - Google Patents

Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid

Info

Publication number
JPS57112329A
JPS57112329A JP18401181A JP18401181A JPS57112329A JP S57112329 A JPS57112329 A JP S57112329A JP 18401181 A JP18401181 A JP 18401181A JP 18401181 A JP18401181 A JP 18401181A JP S57112329 A JPS57112329 A JP S57112329A
Authority
JP
Japan
Prior art keywords
day
arterioschlerosis
quinolyl
chloro
drug against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP18401181A
Other languages
Japanese (ja)
Inventor
Ayanori Takabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP18401181A priority Critical patent/JPS57112329A/en
Publication of JPS57112329A publication Critical patent/JPS57112329A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: The titled pharmaceutical preparation having lowering action on lipid in the blood and low side effect even by long-term medication, comprising 2,3- dihydroxypropyl ester of N-(7-chloro-4-quinolyl)anthranillic acid.
CONSTITUTION: 0.01W100wt%, preferably 1W80wt% compound shown by the formula as an active ingredient is blended with an excipient, bulking agent, binder, wetting agent, to give a drug against arterioschlerosis in the form of powder, granule, tablet, sugar-coated tablet, capsule, supository, suspension, etc. An oral dose is 1W200mg/kg/day, preferably 10W100mg/kg/day, and a parenteral dose is 0.05W5mg/kg/day, preferably 0.2W1mg/kg/day, medicated one W divided four times.
COPYRIGHT: (C)1982,JPO&Japio
JP18401181A 1981-11-17 1981-11-17 Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid Pending JPS57112329A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP18401181A JPS57112329A (en) 1981-11-17 1981-11-17 Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18401181A JPS57112329A (en) 1981-11-17 1981-11-17 Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP1989280A Division JPS56115718A (en) 1980-02-20 1980-02-20 Physiologically active agent containing 2,3- dihydroxypropyl ester of n- 7-chloro-4-quinolyl anthranylic acid

Publications (1)

Publication Number Publication Date
JPS57112329A true JPS57112329A (en) 1982-07-13

Family

ID=16145762

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18401181A Pending JPS57112329A (en) 1981-11-17 1981-11-17 Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid

Country Status (1)

Country Link
JP (1) JPS57112329A (en)

Similar Documents

Publication Publication Date Title
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
KR20030072608A (en) Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
DK555389D0 (en) PHARMACEUTICAL PREPARATION
RU93036959A (en) FREE SOLUBLE MEDICATION WITH SLOW-UP ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES, ASSIGNED FOR RECEPTION INSIDE, THE METHOD OF ITS MANUFACTURE
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
SE7704764L (en) PREPARATION OF ORAL CARRIER BASE AND ITS MANUFACTURED DOSAGE UNITS
JPS5350316A (en) Drug composition for oral administration
JPS57112329A (en) Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid
JPS57112327A (en) Antidiabetic agent comprising 2,3-dihydroxypropyl ester of n-(7-chloro-4-quinolyl)anthranillic acid
JPS57112328A (en) Hypotensor comprising 2,3-dihydroxypropyl ester of n-(7- chloro-4-quinolyl)anthranillic acid
JPS55122715A (en) Antidiabetic agent
JPS6452721A (en) Diabetic remedy containing 7-thiapprostaglandin e1 as active ingredient
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS56115715A (en) Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative
JPS5612318A (en) Agent for suppressing oxidation of lipid
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
JPS54132239A (en) Anti-tumor agent
EP0367509A3 (en) Formulations
JPS55136219A (en) Diazepam oily drug
JPS643123A (en) Remedy for skin inflammation
IE37288B1 (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
IE43848L (en) Pharmaceutical compositions
JPS57114519A (en) Antiarteriosclerotic agent
JPS5640607A (en) Drug composition
JPS57128625A (en) Carcinostatic